2025. 08.27 (수) ~ 2025. 08.29 (금)
부산항국제전시컨벤션센터(BPEX)
제목 | Quantitative Evaluation of Phytosterols and Alcohols for Authenticity of Saw Palmetto Extract Dietary Supplements |
---|---|
작성자 | 이선향 (서강대학교) |
발표구분 | 포스터발표 |
발표분야 | 3. Food & Environment |
발표자 |
이선향 (서강대학교) |
주저자 | 이선향 (서강대학교) |
교신저자 |
오한빈 (서강대학교) |
저자 |
이선향 (서강대학교) 오한빈 (서강대학교) |
Saw palmetto (Serenoa repens) extract is a widely used ingredient in
dietary supplements for prostate health. However, adulteration has been
reported, including blending low-cost vegetable oils (e.g., coconut or palm) to
mimic key marker components. This study evaluated the authenticity of five saw
palmetto extract supplements through quantitative profiling of phytosterols and
long-chain fatty alcohols. Target components were extracted via alkaline
saponification and derivatized for gas chromatography- flame ionization
detector (GC-FID) analysis. Composition profiles were compared with United
States Pharmacopeia (USP) and European Pharmacopeia standards. Results revealed
that none of the samples met USP-specified thresholds for total phytosterols
(≥0.2%) and β-sitosterol (≥0.1%), with measured values of 0.031–0.138% and 0.0023–0.0323%. Conversely,
fatty alcohol content was elevated (0.95–2.27%), exceeding the USP upper limit
(0.35%) by up to fivefold. These findings may reflect variation from analyzing
finished products rather than pure extract. Unlike USP and EP standards, the
Korean pharmacopeia lacks quantitative standards for phytosterols and fatty
alcohols, creating a blind spot allowing low-quality products to enter the
market. Multi-marker profiling may serve as an effective authentication
strategy. This approach provides a scientific foundation for developing quality
control measures and regulatory standards to ensure authenticity of saw
palmetto dietary supplements. *This research was
supported by Basic Science Research Program through the National Research
Foundation of Korea(NRF) funded by the Ministry of
Education(2018R1A6A1A03024940) *This research was supported by a grant (24192MFDS052) from Ministry of Food and Drug Safety in 2025 |